|
1.
|
Google Scholar Link. 2012.
|
|
|
|
|
2.
|
Foulds J, Veldheer S, Berg A. Electronic cigarettes: a response to Leelavathi and Das. Int J Clin Pract. 2012 Apr; 66(4):417-8.
|
|
|
|
|
3.
|
Fagerström K, Russ C, Yu CR, Yunis C, Foulds J. The fagerstrom test for nicotine dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob Res. 2012 Dec; 14(12):1467-73.
|
|
|
|
|
4.
|
Foulds J, Veldheer S. Commentary on Etter & Bullen (2011): could E-cigs become the ultimate nicotine maintenance device? Addiction. 2011 Nov; 106(11):2029-30.
|
|
|
|
|
5.
|
Williams JM, Zimmermann MH, Steinberg ML, Gandhi KK, Delnevo C, Steinberg MB, Foulds J. A comprehensive model for mental health tobacco recovery in new jersey. Adm Policy Ment Health. 2011 Sep; 38(5):368-83.
|
|
|
|
|
6.
|
Oredein T, Foulds J. Causes of the decline in cigarette smoking among African American youths from the 1970s to the 1990s. Am J Public Health. 2011 Oct; 101(10):e4-e14.
|
|
|
|
|
7.
|
Foulds J, Veldheer S, Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract. 2011 Oct; 65(10):1037-42.
|
|
|
|
|
8.
|
Williams JM, Steinberg MB, Steinberg ML, Gandhi KK, Ulpe R, Foulds J. Varenicline for tobacco dependence: panacea or plight? Expert Opin Pharmacother. 2011 Aug; 12(11):1799-812.
|
|
|
|
|
9.
|
Foulds J, Hooper MW, Pletcher MJ, Okuyemi KS. Do smokers of menthol cigarettes find it harder to quit smoking? Nicotine Tob Res. 2010 Dec; 12 Suppl 2:S102-9.
|
|
|
|
|
10.
|
Steinberg ML, Williams JM, Gandhi KK, Foulds J, Brandon TH. Lower task persistence in smokers with schizophrenia as compared to non-psychiatric control smokers. Psychol Addict Behav. 2010 Dec; 24(4):724-9.
|
|
|
|
|
11.
|
Borland R, Fagerström K, Foulds J, McNeill A, Ramström L. FCTC background report on smokeless tobacco is incompatible with WHO scientific reports. Addiction. 2011 Jan; 106(1):225-7.
|
|
|
|
|
12.
|
Steinberg MB, Bover MT, Richardson DL, Schmelzer AC, Williams JM, Foulds J. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. Drug Alcohol Depend. 2011 Mar 1; 114(1):77-81.
|
|
|
|
|
13.
|
Williams JM, Gandhi KK, Lu SE, Kumar S, Shen J, Foulds J, Kipen H, Benowitz NL. Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine Tob Res. 2010 Aug; 12(8):855-9.
|
|
|
|
|
14.
|
Foulds J, Parth JD, Bover-Manderski MT. Blood glucose levels produced by glucose tablets in abstaining smokers. Psychopharmacology (Berl). 2010 Apr; 209(3):283-4.
|
|
|
|
|
15.
|
Foulds J. Use of nicotine replacement therapy to treat nicotine withdrawal syndrome and aid temporary abstinence. Int J Clin Pract. 2010 Feb; 64(3):292-4.
|
|
|
|
|
16.
|
Foulds J, Schmelzer AC, Steinberg MB. Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease. Int J Clin Pract. 2010 Jan; 64(2):142-6.
|
|
|
|
|
17.
|
Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL. Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. Ann Intern Med. 2009 Apr 7; 150(7):447-54.
|
|
|
|
|
18.
|
Gandhi KK, Foulds J, Steinberg MB, Lu SE, Williams JM. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract. 2009 Mar; 63(3):360-7.
|
|
|
|
|
19.
|
Williams JM, Gandhi KK, Karavidas MK, Steinberg ML, Lu SE, Foulds J. Open-Label Study of Craving in Smokers With Schizophrenia Using Nicotine Nasal Spray Compared to Nicotine Patch. J Dual Diagn. 2008 Oct 1; 4(4):355-376.
|
|
|
|
|
20.
|
Foulds J. [Commentary] improving NRT labeling and correcting public misperceptions. Addiction. 2008 Aug; 103(8):1379-80.
|
|
|
|
|
21.
|
Steinberg MB, Schmelzer AC, Richardson DL, Foulds J. The case for treating tobacco dependence as a chronic disease. Ann Intern Med. 2008 Apr 1; 148(7):554-6.
|
|
|
|
|
22.
|
Foulds J, Furberg H. Is low-nicotine Marlboro snus really snus? Harm Reduct J. 2008; 5:9.
|
|
|
|
|
23.
|
Bover MT, Foulds J, Steinberg MB, Richardson D, Marcella SW. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome. Int J Clin Pract. 2008 Feb; 62(2):182-90.
|
|
|
|
|
24.
|
Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007 Aug; 9(8):873-81.
|
|
|
|
|
25.
|
Foulds J, Kozlowski L. Snus--what should the public-health response be? Lancet. 2007 Jun 16; 369(9578):1976-8.
|
|
|
|
|
26.
|
Kozlowski LT, Giovino GA, Edwards B, Difranza J, Foulds J, Hurt R, Niaura R, Sachs DP, Selby P, Dollar KM, Bowen D, Cummings KM, Counts M, Fox B, Sweanor D, Ahern F. Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking. Addict Behav. 2007 Oct; 32(10):2140-50.
|
|
|
|
|
27.
|
Williams JM, Foulds J. Successful tobacco dependence treatment in schizophrenia. Am J Psychiatry. 2007 Feb; 164(2):222-7; quiz 373.
|
|
|
|
|
28.
|
Delnevo C, Lewis MJ, Foulds J. Taxing moist snuff by weight ain't worth spit. Tob Control. 2007 Feb; 16(1):69.
|
|
|
|
|
29.
|
Steinberg MB, Foulds J. Rimonabant for treating tobacco dependence. Vasc Health Risk Manag. 2007; 3(3):307-11.
|
|
|
|
|
30.
|
Han ES, Foulds J, Steinberg MB, Gandhi KK, West B, Richardson DL, Zelenetz S, Dasika J. Characteristics and smoking cessation outcomes of patients returning for repeat tobacco dependence treatment. Int J Clin Pract. 2006 Sep; 60(9):1068-74.
|
|
|
|
|
31.
|
Foulds J, Gandhi KK, Steinberg MB, Richardson DL, Williams JM, Burke MV, Rhoads GG. Factors associated with quitting smoking at a tobacco dependence treatment clinic. Am J Health Behav. 2006 Jul-Aug; 30(4):400-12.
|
|
|
|
|
32.
|
Ziedonis D, Haberstroh S, Hanos Zimmermann M, Miceli M, Foulds J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolesc Med Clin. 2006 Jun; 17(2):381-410.
|
|
|
|
|
33.
|
Ramström LM, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control. 2006 Jun; 15(3):210-4.
|
|
|
|
|
34.
|
Foulds J, Williams JM, Gandhi KK. Racial differences in lung cancer. N Engl J Med. 2006 May 4; 354(18):1951-3; author reply 1951-3.
|
|
|
|
|
35.
|
Foulds J. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. Int J Clin Pract. 2006 May; 60(5):571-6.
|
|
|
|
|
36.
|
Foulds J, Ramstrom L. Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II? Cancer Causes Control. 2006 Mar; 17(2):227-8.
|
|
|
|
|
37.
|
Ziedonis DM
Williams JM,
Steinberg ML,
Foulds J. Primary Psychiatry. Addressing tobacco addiction in office-based management of psychiatric disorders: practical considerations. 2006; 13:51-63.
|
|
|
|
|
38.
|
Delnevo CN, Foulds J, Vorbach U, Kazimir E. Seasonal variations in stage of change among Quitline clients. Tob Control. 2006 Feb; 15(1):70-1.
|
|
|
|
|
39.
|
Foulds J, Steinberg MB, Williams JM, Ziedonis DM. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev. 2006 Jan; 25(1):59-71.
|
|
|
|
|
40.
|
Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006; 29(3):228-35.
|
|
|
|
|
41.
|
Foulds J, Williams J, Order-Connors B, Edwards N, Dwyer M, Kline A, Ziedonis DM. Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment: New Jersey's experience. Alcohol Res Health. 2006; 29(3):236-40.
|
|
|
|
|
42.
|
Steinberg MB, Foulds J, Richardson DL, Burke MV, Shah P. Pharmacotherapy and smoking cessation at a tobacco dependence clinic. Prev Med. 2006 Feb; 42(2):114-9.
|
|
|
|
|
43.
|
Delnevo CD, Foulds J, Hrywna M. Trading tobacco: are youths choosing cigars over cigarettes? Am J Public Health. 2005 Dec; 95(12):2123.
|
|
|
|
|
44.
|
Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res. 2005 Nov 15; 79(2-3):323-35.
|
|
|
|
|
45.
|
Williams JM, Foulds J, Dwyer M, Order-Connors B, Springer M, Gadde P, Ziedonis DM. The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey. J Subst Abuse Treat. 2005 Jun; 28(4):331-40.
|
|
|
|
|
46.
|
Foulds J, Williams J. Tobacco use and cataracts in patients with schizophrenia. Am J Psychiatry. 2005 May; 162(5):1028; author reply 1029.
|
|
|
|
|
47.
|
Delnevo CD, Hrywna M, Foulds J, Steinberg MB. Cigar use before and after a cigarette excise tax increase in New Jersey. Addict Behav. 2004 Dec; 29(9):1799-807.
|
|
|
|
|
48.
|
Steinberg MB, Delnevo CD, Foulds J, Pevzner E. Characteristics of smoking and cessation behaviors among high school students in New Jersey. J Adolesc Health. 2004 Sep; 35(3):231-3.
|
|
|
|
|
49.
|
Williams JM, Ziedonis DM, Foulds J. A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatr Serv. 2004 Sep; 55(9):1064-6.
|
|
|
|
|
50.
|
Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis DM. Advances in pharmacotherapy for tobacco dependence. Expert Opin Emerg Drugs. 2004 May; 9(1):39-53.
|
|
|
|
|
51.
|
Foulds J, Ramstrom L, Burke M, Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control. 2003 Dec; 12(4):349-59.
|
|
|
|
|
52.
|
May S, West R, Hajek P, Nilsson F, Foulds J, Meadow A. The use of videos to inform smokers about different nicotine replacement products. Patient Educ Couns. 2003 Oct; 51(2):143-7.
|
|
|
|
|
53.
|
Krejci J,
Foulds J. Psychiatric Annals. Engaging patients in tobacco dependence treatment: assessment and motivational techniques. 2003; 33:436-444.
|
|
|
|
|
54.
|
Harakas P, Foulds J. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers. Psychopharmacology (Berl). 2002 May; 161(3):271-7.
|
|
|
|
|
55.
|
Foulds J. Effectiveness of smoking cessation initiatives. Smoking cessation services show good return on investment. BMJ. 2002 Mar 9; 324(7337):608-9.
|
|
|
|
|
56.
|
Foulds J, Burke M, Richardson D, Kazimir E. Tobacco dependence treatment services in New Jersey. N J Med. 2002 Mar; 99(3):23-8.
|
|
|
|
|
57.
|
McNeill A, Foulds J, Bates C. Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction. 2001 Dec; 96(12):1757-68.
|
|
|
|
|
58.
|
Herbert M, Foulds J, Fife-Schaw C. No effect of cigarette smoking on attention or mood in non-deprived smokers. Addiction. 2001 Sep; 96(9):1349-56.
|
|
|
|
|
59.
|
Hajek P, West R, Lee A, Foulds J, Owen L, Eiser JR, Main N. Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction. 2001 Mar; 96(3):485-94.
|
|
|
|
|
60.
|
West R, Hajek P, Nilsson F, Foulds J, May S, Meadows A. Individual differences in preferences for and responses to four nicotine replacement products. Psychopharmacology (Berl). 2001 Jan 1; 153(2):225-30.
|
|
|
|
|
61.
|
West R, Hajek P, Foulds J, Nilsson F, May S, Meadows A. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology (Berl). 2000 Apr; 149(3):198-202.
|
|
|
|
|
62.
|
Foulds J. The new NHS smoking campaign BMJ. 2000 Feb 12; 320(7232):454.
|
|
|
|
|
63.
|
Foulds J. The psychology of tobacco addiction: why it is difficult to stop smoking. Monaldi Arch Chest Dis. 1999 Dec; 54(6):495-7.
|
|
|
|
|
64.
|
Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med. 1999 Sep 27; 159(17):2033-8.
|
|
|
|
|
65.
|
Foulds J. Killing for profit: where is the outrage? BMJ. 1999 Jul 24; 319(7204):266.
|
|
|
|
|
66.
|
Foulds J, Russell MA, Jarvis MJ, Feyerabend C. Nicotine absorption and dependence in unlicensed lozenges available over the counter. Addiction. 1998 Sep; 93(9):1427-31.
|
|
|
|
|
67.
|
Foulds J, Stapleton JA, Bell N, Swettenham J, Jarvis MJ, Russell MA. Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug Alcohol Depend. 1997 Mar 14; 44(2-3):105-15.
|
|
|
|
|
68.
|
Foulds J. A role for dopamine in nicotine psychosis? Addiction. 1996 Sep; 91(9):1388-9.
|
|
|
|
|
69.
|
Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell MA. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl). 1996 Sep; 127(1):31-8.
|
|
|
|
|
70.
|
Foulds J. Strategies for smoking cessation. Br Med Bull. 1996 Jan; 52(1):157-73.
|
|
|
|
|
71.
|
Foulds J, Godfrey C. Counting the costs of children's smoking. BMJ. 1995 Oct 28; 311(7013):1152-4.
|
|
|
|
|
72.
|
Foulds J, Ghodse AH. The role of nicotine in tobacco smoking: implications for tobacco control policy. J R Soc Health. 1995 Aug; 115(4):225-30.
|
|
|
|
|
73.
|
Foulds J, Toone B. A case of nicotine psychosis? Addiction. 1995 Mar; 90(3):435-7.
|
|
|
|
|
74.
|
Foulds J, Stapleton J. Evidence that cotinine is psychoactive? Clin Pharmacol Ther. 1995 Jan; 57(1):95-7.
|
|
|
|
|
75.
|
Foulds J,
Ghodse H. . Advances in Psychiatric Treatment. Treatment of tobacco dependence. 1995; 1:116-123.
|
|
|
|
|
76.
|
Foulds J, Bryant A, Stapleton J, Jarvis MJ, Russell MA. The stability of cotinine in unfrozen saliva mailed to the laboratory. Am J Public Health. 1994 Jul; 84(7):1182-3.
|
|
|
|
|
77.
|
Foulds J, McSorley K, Sneddon J, Feyerabend C, Jarvis MJ, Russell MA. Effect of subcutaneous nicotine injections of EEG alpha frequency in non-smokers: a placebo-controlled pilot study. Psychopharmacology (Berl). 1994 Jun; 115(1-2):163-6.
|
|
|
|
|
78.
|
Foulds J. Addiction. Nicotine replacement does work: time to stop sitting on the fence. 1994; 89(4):438-439.
|
|
|
|
|
79.
|
Foulds J. Detrimental effects of nicotine on mood? Addiction. 1994 Feb; 89(2):136-8; discussion 144-6.
|
|
|
|
|
80.
|
Foulds J,
Feyerabend C,
Stapleton J,
Jarvis MJ,
Russell MAH. J Smoking-Related Disorders. Stability of nicotine and cotinine in unfrozen plasma. 1994; 5:41-44.
|
|
|
|
|
81.
|
Foulds J. Does nicotine replacement therapy work? Addiction. 1993 Nov; 88(11):1473-8.
|
|
|
|
|
82.
|
Foulds J, Stapleton J, Hayward M, Russell MA, Feyerabend C, Fleming T, Costello J. Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial. Arch Fam Med. 1993 Apr; 2(4):417-23.
|
|
|
|
|
83.
|
Foulds J. Behav Psychotherapy. Cerebral circulation during treatment of blood-injury phobia: a case study. 1993; 21:137-146.
|
|
|
|
|
84.
|
Jarvis MJ, Foulds J, Feyerabend C. Exposure to passive smoking among bar staff. Br J Addict. 1992 Jan; 87(1):111-3.
|
|
|
|
|
85.
|
Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MA. Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berl). 1992; 106(3):421-7.
|
|
|
|
|
86.
|
Foulds J, Wiedmann K, Patterson J, Brooks N. The effects of muscle tension on cerebral circulation in blood-phobic and non-phobic subjects. Behav Res Ther. 1990; 28(6):481-6.
|
|
|
|
|
87.
|
Crawford JR, Stewart LE, Cochrane RH, Foulds JA, Besson JA, Parker DM. Estimating premorbid IQ from demographic variables: regression equations derived from a UK sample. Br J Clin Psychol. 1989 Sep; 28 ( Pt 3):275-8.
|
|
|
|
|
88.
|
Foulds J, McAllister H, Foulds S. J Psychophysiol. The relationship between socialization and electrodermal activity in normal subjects. 1988; 2:227-230.
|
|
|
|